prednisone
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
National Heart, Lung, and Blood Institute (NHLBI)
Overview
prednisone is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
prednisone clinical trials
Explore related
Medical disclaimer. This page summarizes research about prednisone for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.